Operating Metrics 營運指標
Sanofi (SNY) Operating Metrics 營運指標
Sanofi SNY 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-06-30
最新營運指標
- Dupixent Sales
- €17,726M · 2026-06-30 來源：Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR
- Pharma Launches Sales
- €4,643M · 2026-06-30 來源：Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR
- Vaccines Sales
- €7,839M · 2026-06-30 來源：Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR
- ALTUVIIIO Sales
- €1,292M · 2026-06-30 來源：Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR
- Beyfortus Sales
- €1,817M · 2026-06-30 來源：Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR
- Regulatory Approvals
- 24 approvals · 2026-06-30 來源：Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR、Sanofi / SEC EDGAR
季度趨勢
| 指標 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 |
|---|---|---|---|---|---|---|---|---|
| Dupixent Sales | €5,154M | €4,170M | €4,246M | €4,156M | €3,832M | €3,480M | €3,458M | €3,476M |
| Pharma Launches Sales | €1,305M | €1,171M | €1,121M | €1,046M | €897M | €847M | €827M | €727M |
| Vaccines Sales | €1,150M | €1,293M | €2,039M | €3,357M | €1,214M | €1,326M | €2,177M | €3,802M |
| ALTUVIIIO Sales | €349M | €325M | €324M | €294M | €291M | €251M | €230M | €172M |
| Beyfortus Sales | €108M | €284M | €686M | €739M | €72M | €284M | €841M | €645M |
| Regulatory Approvals | 7 approvals | 5 approvals | 10 approvals | 2 approvals | 3 approvals | 6 approvals | 4 approvals | 4 approvals |
資料來源
- Sanofi Q2 2026 results · Sanofi / SEC EDGAR · 2026-07-30
- Sanofi Q1 2026 results · Sanofi / SEC EDGAR · 2026-04-23
- Sanofi Q4 and full-year 2025 results · Sanofi / SEC EDGAR · 2026-01-29
- Sanofi Q3 2025 results · Sanofi / SEC EDGAR · 2025-10-24
- Sanofi Q2 2025 results · Sanofi / SEC EDGAR · 2025-07-31
- Sanofi Q1 2025 results · Sanofi / SEC EDGAR · 2025-04-24
- Sanofi Q4 and full-year 2024 results · Sanofi / SEC EDGAR · 2025-01-30
- Sanofi Q3 2024 results · Sanofi / SEC EDGAR · 2024-10-25